Treatment of lumbar degenerative disease with modified transforaminal lumbar interbody fusion
10.3760/cma.j.issn.1673-4904.2011.23.007
- VernacularTitle:改良经椎间孔椎体间融合术治疗腰椎退变性疾病
- Author:
Yang LIU
;
Qun YANG
;
Kai TANG
;
Kai MA
;
Changming JIANG
;
Chunming WU
;
Hong WANG
- Publication Type:Journal Article
- Keywords:
Lumbar vertebrae;
Degenerative disease;
Transforaminal lumbar interbody fusion;
Modified
- From:
Chinese Journal of Postgraduates of Medicine
2011;34(23):18-20
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the chnical effect of modified transforaminal lumbar interbody fusion (TLIF) on the treatment of lumbar degenerative disease. Methods Sixty-two patients with lumbar degenerative disease were treated by the modified TLIF from June 2007 to May 2009. The preoperative diagnosis was lumbar intervertebral disc herniation with spinal instability (28 cases), lumbar intervertebral disc herniation with lumbar stenosis (27 cases ), degenerative spondylohsthesis (7 cases ). Forty-eight cases were single-level and 14 cases were two-level. The patients were evaluated by observing the fusion rate and comparing the visual analog score( VAS ) and Japanese orthopaedics association (JOA) score of preoperation with those of postoperation. Results All the patients were followed up from 15 to 30 (22.77 ± 3.82)months,no nerve injury,leakage of cerebralspinal,infection,the broken of pedical screws and other complications. The fusion rate of segment was 96.8% at the follow-up after 1 year postoperatively. Judgement by JOA score,the rate of improvement was 93.5%(58/62),excellent in 34 cases,good in 24 cases,fair in 4 cases. The postoperative value of V AS and JOA score were higher than those of preoperation (P ＜ 0.05 ), the values when follow-up of 3 months was performed had no statistic al difference with those of final follow-up (P＞0.05). Conclusion The modified TLIF with fully decompression while reducing the accessing spinal canal complications have good clinical efficacy in treating lumbar degenerative disease.
